Lista de obras - Susanna Schraen - Dominio Público Uruguay

A diagnostic scale for Alzheimer's disease based on cerebrospinal fluid biomarker profiles

artículo científico publicado en 2014

A new decision tree combining Abeta 1-42 and p-Tau levels in Alzheimer's diagnosis.

artículo científico publicado en 2013

A new locus for spinocerebellar ataxia (SCA21) maps to chromosome 7p21.3-p15.1

artículo científico publicado en 2002

Absence of unidentified CAG repeat expansion in patients with Huntington's disease-like phenotype

artículo científico publicado en 2000

Altered splicing of Tau in DM1 is different from the foetal splicing process.

artículo científico publicado en 2009

Analysis of ERDA1, CTG18.1, and uncloned CAG/CTG repeat sequences in familial Parkinson's disease with anticipation

artículo científico publicado en 1999

Analysis of a Compartmental Model of Endogenous Immunoglobulin G Metabolism with Application to Multiple Myeloma.

artículo científico publicado en 2017

Association of plasma amyloid with risk of dementia: The prospective Three-City Study

scientific article published on 01 September 2009

Association of plasma β-amyloid with MRI markers of structural brain aging the 3-City Dijon study.

artículo científico publicado en 2015

Aβ1-40 and Aβ1-42 Plasmatic Levels In Stroke: Influence of Pre-Existing Cognitive Status and Stroke Characteristics

artículo científico

Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology.

artículo científico publicado en 2011

Biochemistry of Tau in Alzheimer's disease and related neurological disorders.

artículo científico publicado en 2008

Central Nervous System and Peripheral Inflammatory Processes in Alzheimer's Disease: Biomarker Profiling Approach.

artículo científico publicado en 2015

Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stage.

artículo científico publicado en 2018

Cerebrospinal fluid collection tubes: a critical issue for Alzheimer disease diagnosis.

artículo científico publicado en 2012

Definite behavioral variant of frontotemporal dementia with C9ORF72 expansions despite positive Alzheimer's disease cerebrospinal fluid biomarkers.

artículo científico publicado en 2012

Development of new quantitative mass spectrometry and semi-automatic isofocusing methods for the determination of Apolipoprotein E typing.

artículo científico publicado en 2015

Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies.

artículo científico publicado en 2016

Diffuse form of argyrophilic grain disease: a new variant of four-repeat tauopathy different from limbic argyrophilic grain disease ⬇️

artículo científico publicado el 27 de septiembre de 2003

ETR-3 represses Tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I.

artículo científico publicado en 2006

Genome-wide Association Study Links APOEϵ4 and BACE1 Variants with Plasma Amyloid β Levels

Heavy + light chain analysis to assign myeloma response is analogous to the IMWG response criteria

artículo científico publicado en 2017

Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy

artículo científico publicado en 2016

IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma.

artículo científico publicado en 2014

IgMκ and IgMλ Measurements for the Assessment of Patients with Waldenström's Macroglobulinaemia.

artículo científico publicado en 2016

Impact of harmonization of collection tubes on Alzheimer's disease diagnosis.

artículo científico publicado en 2013

Impact of the 2008-2012 French Alzheimer Plan on the use of cerebrospinal fluid biomarkers in research memory center: the PLM Study

artículo científico publicado en 2013

Inferior Parietal Cortex Hypoperfusion is the Most Specific Imaging Marker for AD Patients With Positive CSF Biomarker Assays in a Memory Clinic in France.

artículo científico publicado en 2017

Intersite variability of CSF Alzheimer's disease biomarkers in clinical setting

artículo científico publicado en 2012

Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study

artículo científico publicado en 2012

Microtubule-associated protein tau gene: a risk factor in human neurodegenerative diseases.

artículo científico publicado en 2004

Mis-splicing of Tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing.

artículo científico publicado en 2011

Neurofilament ELISA validation.

artículo científico publicado en 2009

Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats.

artículo científico publicado en 2007

Plasma amyloid-β levels and prognosis in incident dementia cases of the 3-City Study

artículo científico publicado en 2013

Plasma β-amyloid 40 levels are positively associated with mortality risks in the elderly.

artículo científico publicado en 2014

Real time RT-PCR shows correlation between retinoid-induced apoptosis and NGF-R mRNA levels.

artículo científico publicado en 2001

Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF biomarkers

artículo científico publicado en 2018

Risk of Alzheimer's Disease Biological Misdiagnosis Linked to Cerebrospinal Collection Tubes

artículo científico publicado en 2012

Role of IRF4 in resistance to immunomodulatory (IMid) compounds® in Waldenström's macroglobulinemia.

artículo científico publicado en 2017

Simple nonisotopic assays for detection of (CAG)n repeats expansions associated with seven neurodegenerative disorders

artículo científico publicado en 1998

Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity.

artículo científico publicado en 2016

Tau as a biomarker of neurodegenerative diseases.

artículo científico publicado en 2008

Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2.

artículo científico publicado en 2014

The first European family with tibial muscular dystrophy outside the Finnish population

artículo científico publicado en 1998

The first identified French family with dentatorubral-pallidoluysian atrophy.

artículo científico publicado en 2000

The novel retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphtalene carboxylic acid can trigger apoptosis through a mitochondrial pathway independent of the nucleus.

artículo científico publicado en 1999

The relationship between CSF biomarkers and cerebral metabolism in early-onset Alzheimer's disease

artículo científico publicado en 2018

Utility of CSF biomarkers in psychiatric disorders: a national multicentre prospective study

artículo científico publicado en 2016

What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects?

artículo científico publicado en 2016

[Biological markers in Alzheimer disease: what are the chances for less slow diagnosis?]

artículo científico publicado en 2009

[Molecular actors in Alzheimer's disease: which diagnostic and therapeutic consequences?].

artículo científico publicado en 2010

[Triplet expansion diseases]

artículo científico publicado en 2000

cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases

artículo científico publicado en 2010

Lista de obras de Susanna Schraen

A diagnostic scale for Alzheimer's disease based on cerebrospinal fluid biomarker profiles

A new decision tree combining Abeta 1-42 and p-Tau levels in Alzheimer's diagnosis.

A new locus for spinocerebellar ataxia (SCA21) maps to chromosome 7p21.3-p15.1

Absence of unidentified CAG repeat expansion in patients with Huntington's disease-like phenotype

Altered splicing of Tau in DM1 is different from the foetal splicing process.

Analysis of ERDA1, CTG18.1, and uncloned CAG/CTG repeat sequences in familial Parkinson's disease with anticipation

Analysis of a Compartmental Model of Endogenous Immunoglobulin G Metabolism with Application to Multiple Myeloma.

Association of plasma amyloid with risk of dementia: The prospective Three-City Study

Association of plasma β-amyloid with MRI markers of structural brain aging the 3-City Dijon study.

Aβ1-40 and Aβ1-42 Plasmatic Levels In Stroke: Influence of Pre-Existing Cognitive Status and Stroke Characteristics

Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology.

Biochemistry of Tau in Alzheimer's disease and related neurological disorders.

Central Nervous System and Peripheral Inflammatory Processes in Alzheimer's Disease: Biomarker Profiling Approach.

Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stage.

Cerebrospinal fluid collection tubes: a critical issue for Alzheimer disease diagnosis.

Definite behavioral variant of frontotemporal dementia with C9ORF72 expansions despite positive Alzheimer's disease cerebrospinal fluid biomarkers.

Development of new quantitative mass spectrometry and semi-automatic isofocusing methods for the determination of Apolipoprotein E typing.

Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies.

Diffuse form of argyrophilic grain disease: a new variant of four-repeat tauopathy different from limbic argyrophilic grain disease ⬇️

ETR-3 represses Tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I.

Genome-wide Association Study Links APOEϵ4 and BACE1 Variants with Plasma Amyloid β Levels

Heavy + light chain analysis to assign myeloma response is analogous to the IMWG response criteria

Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy

IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma.

IgMκ and IgMλ Measurements for the Assessment of Patients with Waldenström's Macroglobulinaemia.

Impact of harmonization of collection tubes on Alzheimer's disease diagnosis.

Impact of the 2008-2012 French Alzheimer Plan on the use of cerebrospinal fluid biomarkers in research memory center: the PLM Study

Inferior Parietal Cortex Hypoperfusion is the Most Specific Imaging Marker for AD Patients With Positive CSF Biomarker Assays in a Memory Clinic in France.

Intersite variability of CSF Alzheimer's disease biomarkers in clinical setting

Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study

Microtubule-associated protein tau gene: a risk factor in human neurodegenerative diseases.

Mis-splicing of Tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing.

Neurofilament ELISA validation.

Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats.

Plasma amyloid-β levels and prognosis in incident dementia cases of the 3-City Study

Plasma β-amyloid 40 levels are positively associated with mortality risks in the elderly.

Real time RT-PCR shows correlation between retinoid-induced apoptosis and NGF-R mRNA levels.

Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF biomarkers

Risk of Alzheimer's Disease Biological Misdiagnosis Linked to Cerebrospinal Collection Tubes

Role of IRF4 in resistance to immunomodulatory (IMid) compounds® in Waldenström's macroglobulinemia.

Simple nonisotopic assays for detection of (CAG)n repeats expansions associated with seven neurodegenerative disorders

Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity.

Tau as a biomarker of neurodegenerative diseases.

Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2.

The first European family with tibial muscular dystrophy outside the Finnish population

The first identified French family with dentatorubral-pallidoluysian atrophy.

The novel retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphtalene carboxylic acid can trigger apoptosis through a mitochondrial pathway independent of the nucleus.

The relationship between CSF biomarkers and cerebral metabolism in early-onset Alzheimer's disease

Utility of CSF biomarkers in psychiatric disorders: a national multicentre prospective study

What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects?

[Biological markers in Alzheimer disease: what are the chances for less slow diagnosis?]

[Molecular actors in Alzheimer's disease: which diagnostic and therapeutic consequences?].

[Triplet expansion diseases]

cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases